# US 2021/0174899 A1 · Machine learning techniques for gene expression analysis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0174899 A1
- Document ID: US20210174899A1
- Status: Published application
- Kind: A1
- Application number: 17/113,008
- Filed: 2020-12-05
- Published: 2021-06-10
- Earliest claimed: 2019-12-05
- Assignees: BostonGene Corporation
- Applicants: BostonGene Corporation
- Inventors: Zoia Antysheva; Viktor Svekolkin; Nikita Kotlov; Anton Karelin; Ekaterina Postovalova
- Web page: https://patentgrep.com/patent/US20210174899A1

## CPC

- G16B 20/00: ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B 25/10: Gene or protein expression profiling; Expression-ratio estimation or normalisation
- G16B 5/20: Probabilistic models
- G16B 40/00: ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16H 50/20: for computer-aided diagnosis, e.g. based on medical expert systems
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

Techniques for determining one or more characteristics of a biological sample using rankings of gene expression levels in expression data obtained using one or more sequencing platforms is described. The techniques may include obtaining expression data for a biological sample of a subject. The techniques further include ranking genes in a set of genes based on their expression levels in the expression data to obtain a gene ranking and determining using the gene ranking and a statistical model, one or more characteristics of the biological sample.

## Claims

### Claim 1

A system, comprising:
at least one computer hardware processor; and
at least one non-transitory computer-readable storage medium storing processor executable instructions that, when executed by the at least one computer hardware processor, cause the at least one computer hardware processor to perform:
obtaining expression data obtained at least in part by sequencing a biological sample of a subject having, suspected of having or at risk of having cancer, the expression data comprising expression levels for a plurality of genes, the plurality of genes comprising a set of genes;
ranking at least some genes in the set of genes, based on their expression levels in the expression data to obtain a gene ranking; and
determining, using the gene ranking and a statistical model trained using training data indicating a plurality of gene rankings of at least some of the genes in the set of genes obtained, at least one characteristic of the biological sample, wherein each of the plurality of gene rankings is obtained based on respective expression levels for the at least some genes in the set of genes,
wherein the at least one characteristic of the biological sample is a physiological characteristic of cells in the biological sample or a tissue from which the cells originate.

### Claim 2 (depends on 1)

The system of claim 1, wherein the at least one characteristic is selected from the group consisting of cancer grade for cells in the biological sample, tissue of origin for cells in the biological sample, tissue type for cells in the biological sample, and cancer subtype for cells in the biological sample.

### Claim 3 (depends on 1)

The system of claim 1, wherein the at least one characteristic includes cancer grade for cells in the biological sample, and the cancer grade is selected from the group consisting of Grade 1, Grade 2, Grade 3, Grade 4, and Grade 5.

### Claim 4 (depends on 1)

The system of claim 1, wherein the at least one characteristic includes tissue of origin for cells in the biological sample, and the tissue of origin is selected from the group consisting of lung tissue, pancreas tissue, stomach tissue, colon tissue, liver tissue, bladder tissue, kidney tissue, thyroid tissue, lymph node tissue, adrenal gland tissue, skin tissue, breast tissue, ovary tissue, prostate tissue, urothelial tissue, cervical tissue, esophagus tissue, brain tissue, soft tissue, connective tissue, head tissue, and neck tissue.

### Claim 5 (depends on 1)

The system of claim 1, wherein the at least one characteristic includes tissue type for cells in the biological sample, and the tissue type is selected from the group consisting of adenocarcinoma, squamous cell carcinoma, carcinoma, cystadenocarcinoma, sarcoma, and glioma.

### Claim 6 (depends on 1)

The system of claim 1, wherein the at least one characteristic includes human papillomavirus (HPV) status for cells in the biological sample, and wherein the set of genes includes at least 5 genes selected from the group of genes listed in Table 8.

### Claim 7 (depends on 1)

The system of claim 1, wherein the at least one characteristic includes a subtype of peripheral T-cell lymphoma (PTCL) for cells in the biological sample, and wherein the set of genes includes at least 5 genes selected from the group of genes listed in Table 10.

### Claim 8 (depends on 7)

The system of claim 7, wherein the subtype of PTCL is selected from the group consisting of: anaplastic large cell lymphoma (ALCL), angioimmunoblastic T-cell lymphoma (AITL), natural killer/T-cell lymphoma (NKTCL), and adult T-cell leukemia/lymphoma (ATLL).

### Claim 9 (depends on 1)

The system of claim 1, wherein the at least one computer hardware processor is further configured to perform presenting, to a user, an indication of the at least one characteristic via a graphical user interface (GUI).

### Claim 10 (depends on 1)

The system of claim 1, wherein determining the at least one characteristic further comprises providing the gene ranking as an input to the statistical model and obtaining an output indicating the at least one characteristic.

### Claim 11

A method, comprising:
using at least one computer hardware processor to perform:
obtaining expression data obtained at least in part by sequencing a biological sample of a subject having, suspected of having or at risk of having cancer, the expression data comprising expression levels for a plurality of genes, the plurality of genes comprising a set of genes;
ranking at least some genes in the set of genes, based on their expression levels in the expression data to obtain a gene ranking; and
determining, using the gene ranking and a statistical model trained using training data indicating a plurality of gene rankings of at least some of the genes in the set of genes obtained, at least one characteristic of the biological sample, wherein each of the plurality of gene rankings is obtained based on respective expression levels for the at least some genes in the set of genes,
wherein the at least one characteristic of the biological sample is a physiological characteristic of cells in the biological sample or a tissue from which the cells originate.

### Claim 12 (depends on 11)

The method of claim 11, wherein the at least one characteristic includes cancer grade for cells in the biological sample.

### Claim 13 (depends on 12)

The method of claim 12, wherein the subject has, is suspected of having, or is at risk of having breast cancer, and wherein the set of genes comprises at least 5 genes selected from the group of genes listed in Table 1.

### Claim 14 (depends on 13)

The method of claim 13, wherein the set of genes comprises at least 10 genes selected from the group of genes listed in Table 1.

### Claim 15 (depends on 12)

The method of claim 12, wherein the subject has, is suspected of having, or is at risk of having kidney cancer, and wherein the set of genes comprises at least 5 genes selected from the group of genes listed in Table 2.

### Claim 16 (depends on 12)

The method of claim 12, wherein the subject has, is suspected of having, or is at risk of having lymphoma, and wherein the set of genes comprises at least 5 genes selected from the group of genes listed in Table 3.

### Claim 17 (depends on 16)

The method of claim 16, wherein the subject has, is suspected of having, or is at risk of having Diffuse Large B-Cell Lymphoma (DLBCL), the set of genes comprises at least 10 genes selected from the group of genes listed in Table 3, and the at least one characteristic is a cell of origin selected from the group consisting of germinal center B-cell (GCB) and activated B-cell (ABC).

### Claim 18 (depends on 12)

The method of claim 12, wherein the subject has, is suspected of having, or is at risk of having lung adenocarcinoma, and wherein the set of genes comprises at least 5 genes selected from the group of genes listed in Table 6.

### Claim 19 (depends on 11)

The method of claim 11, wherein the at least one characteristic is selected from the group consisting of cancer grade for cells in the biological sample, tissue of origin for cells in the biological sample, tissue type for cells in the biological sample, and cancer subtype for cells in the biological sample.

### Claim 20

At least one non-transitory computer-readable storage medium storing processor-executable instructions that, when executed by the at least one computer hardware processor, cause the at least one computer hardware processor to perform a method comprising:
obtaining expression data obtained at least in part by sequencing a biological sample of a subject having, suspected of having or at risk of having cancer, the expression data comprising expression levels for a plurality of genes, the plurality of genes comprising a set of genes;
ranking at least some genes in the set of genes, based on their expression levels in the expression data to obtain a gene ranking; and
determining, using the gene ranking and a statistical model trained using training data indicating a plurality of gene rankings of at least some of the genes in the set of genes obtained, at least one characteristic of the biological sample, wherein each of the plurality of gene rankings is obtained based on respective expression levels for the at least some genes in the set of genes,
wherein the at least one characteristic of the biological sample is a physiological characteristic of cells in the biological sample or a tissue from which the cells originate.

### Claim 21 (depends on 20)

The at least one non-transitory computer-readable storage medium of claim 20, wherein determining the gene ranking comprises determining a relative rank for each gene in the set of genes based on the expression levels.

### Claim 22 (depends on 20)

The at least one non-transitory computer-readable storage medium of claim 20, wherein the statistical model comprises a gradient boosted decision tree classifier.

### Claim 23 (depends on 20)

The at least one non-transitory computer-readable storage medium of claim 20, wherein determining the at least one characteristic further comprises providing the gene ranking as an input to the statistical model and obtaining an output indicating the at least one characteristic.

### Claim 24 (depends on 20)

The at least one non-transitory computer-readable storage medium of claim 20, wherein the at least one characteristic is selected from the group consisting of cancer grade for cells in the biological sample, tissue of origin for cells in the biological sample, tissue type for cells in the biological sample, and cancer subtype for cells in the biological sample.

### Claim 25 (depends on 20)

The at least one non-transitory computer-readable storage medium of claim 20, wherein the subject has, is suspected of having, or is at risk of having head and neck squamous cell carcinoma, and wherein the set of genes comprises at least 5 genes selected from the group of genes listed in Table 8.

### Claim 26 (depends on 25)

The at least one non-transitory computer-readable storage medium of claim 25, wherein the set of genes comprises at least 10 genes selected from the group of genes listed in Table 8.

### Claim 27 (depends on 25)

The at least one non-transitory computer-readable storage medium of claim 25, wherein the at least one characteristic includes human papillomavirus (HPV) status for cells in a biological sample.

### Claim 28 (depends on 20)

The at least one non-transitory computer-readable storage medium of claim 20, wherein the at least one characteristic includes a subtype of peripheral T-cell lymphoma (PTCL) for cells in the biological sample, and wherein the set of genes includes at least 5 genes selected from the group of genes listed in Table 10.

### Claim 29 (depends on 28)

The at least one non-transitory computer-readable storage medium of claim 28, wherein the set of genes comprises at least 10 genes selected from the groups of genes listed in Table 10.

### Claim 30 (depends on 28)

The at least one non-transitory computer-readable storage medium of claim 28, wherein the subtype of PTCL is selected from the group consisting of: anaplastic large cell lymphoma (ALCL), angioimmunoblastic T-cell lymphoma (AITL), natural killer/T-cell lymphoma (NKTCL), and adult T-cell leukemia/lymphoma (ATLL).
